231 related articles for article (PubMed ID: 37718369)
1. Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations.
Fedorchenko Y; Mahmudov K; Abenov Z; Zimba O; Yessirkepov M
Rheumatol Int; 2023 Dec; 43(12):2167-2174. PubMed ID: 37718369
[TBL] [Abstract][Full Text] [Related]
2. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
3. Burden of comorbidities and medication use in childbearing women with rheumatic diseases: a nationwide population-based study.
Chung MK; Lee CH; Park JS; Lim H; Lee J
Korean J Intern Med; 2022 Nov; 37(6):1250-1259. PubMed ID: 34233434
[TBL] [Abstract][Full Text] [Related]
4. Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients.
Chen HH; Chen DY; Lin CC; Chen YM; Lai KL; Lin CH
Ther Clin Risk Manag; 2017; 13():583-592. PubMed ID: 28496328
[TBL] [Abstract][Full Text] [Related]
5. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
[TBL] [Abstract][Full Text] [Related]
6. Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses.
Mehta P; Gasparyan AY; Zimba O; Kitas GD; Yessirkepov M
Clin Rheumatol; 2022 Dec; 41(12):3897-3913. PubMed ID: 36076125
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus.
Penn SK; Kao AH; Schott LL; Elliott JR; Toledo FG; Kuller L; Manzi S; Wasko MC
J Rheumatol; 2010 Jun; 37(6):1136-42. PubMed ID: 20436082
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary pathology of the rheumatic diseases.
Leslie KO; Trahan S; Gruden J
Semin Respir Crit Care Med; 2007 Aug; 28(4):369-78. PubMed ID: 17764055
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine Therapy and Serum Immunoglobulin Levels in Women with IgG Subclass Deficiency and Systemic Lupus Erythematosus, Sjögren Syndrome, and Rheumatoid Arthritis: A Retrospective Study.
Barton JC; Barton JC; Bertoli LF
Arch Immunol Ther Exp (Warsz); 2022 Apr; 70(1):14. PubMed ID: 35403913
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
Front Immunol; 2021; 12():631869. PubMed ID: 33868251
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of patients with rheumatic diseases and abnormal liver function].
Wu CY; Li MC; Duan XW; Li HB; Wang YH; Li Q; Luo H; Xu J; Wu LJ; Wang YF; Zhao C; Fang YF; Lin SD; Xu D; Tian XP; Li MT; Zeng XF
Zhonghua Nei Ke Za Zhi; 2023 Sep; 62(9):1102-1113. PubMed ID: 37650184
[No Abstract] [Full Text] [Related]
12. Expert Group Consensus Opinion: Role of Anti-inflammatory Agents in the Management of Type-2 Diabetes (T2D).
Das AK; Kalra S; Tiwaskar M; Bajaj S; Seshadri K; Chowdhury S; Sahay R; Indurkar S; Unnikrishnan AG; Phadke U; Pareek A; Purkait I
J Assoc Physicians India; 2019 Dec; 67(12):65-74. PubMed ID: 31801334
[TBL] [Abstract][Full Text] [Related]
13. Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents.
Infante M; Padilla N; Alejandro R; Caprio M; Della-Morte D; Fabbri A; Ricordi C
Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35629988
[TBL] [Abstract][Full Text] [Related]
14. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.
Alqatari S; Nemer A; Hasan M; Bukhari R; Al Argan R; Al Khafaji D; Alwaheed A; Alzaki A; Al-Wazza M; Al Warthan S; Al Saeed A; Albeladi F; Almeer H; AlSulaiman R; Abu Quren A
J Med Life; 2023 Jun; 16(6):873-882. PubMed ID: 37675163
[TBL] [Abstract][Full Text] [Related]
16. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
[TBL] [Abstract][Full Text] [Related]
17. Risk of New-Onset Diabetes Mellitus Associated with Antirheumatic Drugs in Patients with Rheumatoid Arthritis: A Nationwide Population Study.
Nam SH; Kim M; Kim YJ; Ahn SM; Hong S; Lee CK; Yoo B; Oh JS; Kim YG
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456202
[TBL] [Abstract][Full Text] [Related]
18. Distribution and clinical significance of anti-carbamylation protein antibodies in rheumatological diseases among the Chinese Han population.
Dong R; Sun Y; Xu W; Xiang W; Li M; Yang Q; Zhu L; Ma Z
Front Immunol; 2023; 14():1197458. PubMed ID: 37539050
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?
Dima A; Jurcut C; Arnaud L
Joint Bone Spine; 2021 May; 88(3):105143. PubMed ID: 33515791
[TBL] [Abstract][Full Text] [Related]
20. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
Hu C; Lu L; Wan JP; Wen C
Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
